3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Pancreatic Neoplasms
3
Inflammation
2
Glioblastoma
2
Frailty
2
Recurrence
1
Polycystic Ovary Syndrome
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Myofibroma
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Hodgkin Disease
1
Hemorrhage
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Anemia
1
Adenomyosis
1
Adenocarcinoma
1
Interventions
Geriatric Assessment
5
epigallocatechin gallate
2
Standard of Care
2
Ascorbic Acid
2
peflavit
1
microcrystalline cellulose
1
fisetin
1
diacetamate
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Quercetin
1
Psychosocial Intervention
1
Methods
1
Flavonoids
1
Enhanced Recovery After Surgery
1
Data Collection
1
Dasatinib
1
Control Groups
1
Chemotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Frailty
×
Ascorbic Acid
×
1 year
×
Clear all
NCT04553666
2026-05-07
ReFOCUS1
University of Rochester
Phase 2
Completed
24 enrolled
17 charts
NCT06068543
2026-03-06
ReFOCUS2
University of Rochester
Phase 2
Recruiting
118 enrolled